블로그

Zepzelca가 나에게 맞을까요? 치료, 비용 및 안전성 가이드

A nurse comforting a patient receiving infusion therapy

If you are living with small-cell lung cancer and chemotherapy has not been effective, a new treatment called Zepzelca may be an option for you.

Studies suggest Zepzelca can be more effective in treating small-cell lung cancer (SCLC) than other currently available medications in specific scenarios. In this article, we will explore everything you need to know about Zepzelca, including its dosing, side effects, cost, and more.

재정 지원 받기

(866) 631-1684

What Is Zepzelca?

Zepzelca (lurbinectedin) is an FDA-approved chemotherapy medication used to treat small-cell lung cancer. The FDA first approved this medication on June 15, 2020 [1].

If your cancer has spread to other parts of your body and other medications (e.g., platinum-based chemotherapy) haven’t worked well, ask your oncologist if this treatment is right for you.

Zepzelca is a chemotherapy medication called an alkylating agent. It works by attaching to the DNA (genetic material) of the cancer cells to stop their ability to grow and multiply.

It is given through an infusion through the veins (intravenous or IV), which takes about 1 hour. Some common side effects include tiredness, diarrhea, nausea, and constipation.

What Is Zepzelca Used for?

You can use Zepzelca when your small-cell lung cancer has:

  • Spread to other parts of your body
  • Gotten worse after you had other treatments like platinum-based chemotherapy

Keep in mind that the FDA approved this medication quickly based on how well it worked and how long the benefits lasted. However, its continued approval depends on further studies.

How Does It Work?

Zepzelca is an alkylating agent. It attaches to a specific part of the DNA of cancer cells and stops them from replicating. As a result, the cancer cells aren’t able to multiply, and they eventually die [2].

부작용

A woman holding her chest and coughing

Like any other medication, Zepzelca can have some side effects [3].

일반적인 부작용

Common side effects include:

  • 설사
  • Trouble breathing
  • 메스꺼움
  • Tiredness
  • Low levels of sodium and magnesium in the blood
  • 변비
  • Low white and red blood cell counts
  • Low level of albumin in the blood
  • 식욕 감소
  • Increased kidney and liver function blood test
  • Increased blood sugar
  • Muscle and joint pain
  • Cough and vomiting

전문가와 상담하세요

공제금 지원에 관하여
자세히 알아보기

Severe Side Effects

Severe side effects of Zepzelca include:

Severe Neutropenia: In this condition, your white blood cell levels become abnormally low. This raises your chance of getting life-threatening infections. During treatment, the provider will regularly monitor your white blood cell counts. If your white blood cells become too low, your provider may adjust your dose or delay treatment.

Liver Problems: Zepzelca chemotherapy medication can damage your liver. Symptoms of liver problems include loss of appetite, pain on the right side of your stomach, and nausea or vomiting. Liver function tests (LFTs) are blood results that can indicate how healthy your liver is. Your provider will regularly monitor your LFTs during Zepzelca treatment to ensure your liver is healthy.

Severe Muscle Problems: This medication can cause severe muscle pain or weakness. Inform your provider immediately if you encounter these symptoms.

Leakage of Zepzelca Out of Your Vein During the Infusion: If Zepzelca leaks out of your vein during the infusion, it can damage the surrounding tissue and cause tissue death. If this happens, you will need urgent treatment at a hospital. During the infusion, if you see any leakage out of your vein or feel sudden pain or burning around the infusion site, tell your provider immediately.

Please note that this is not a list of all possible side effects. If you encounter any severe side effects, consult your provider immediately.

What Are the Clinical Benefits of Zepzelca?

A clinical study was conducted on 105 patients with small-cell lung cancer (SCLC) whose cancer got worse after receiving platinum-based chemotherapy. All the patients in the study received Zepzelca. Researchers found that 35% of all patients receiving this drug saw a reduction in their tumor size, with a median response of 5.3 months [1]. Compared to traditional medications, Zepzelca was more effective.

Zepzelca Dosing Information

You can get Zepzelca as an intravenous infusion. Home infusion treatments take about an hour to complete. You may also receive some anti-nausea medications shortly before the infusion to help prevent nausea.

The dosage depends on your body’s surface area. The usual dose is 3.2 mg/m2 given once every 21 days. You will continue receiving this treatment until your cancer worsens or you experience bothersome or serious side effects [2].

Your provider will determine the right dosage for you based on your specific clinical situation. So, always follow your provider’s advice. Your prescriber will also regularly monitor you during treatment to manage any side effects you might be experiencing.

Before Receiving Zepzelca

Before you start your chemotherapy treatment with Zepzelca:

  • Tell your provider if you are allergic to lurbinectedin or any of the ingredients in lurbinectedin injection.
  • Inform your provider if you are pregnant or want to become pregnant. The medication may harm your unborn baby, so it shouldn’t be taken during pregnancy. If you are a female, able to become pregnant, and are receiving Zepzelca, you should use birth control during the treatment and for 6 months after the final dose. If you are a male recipient with a female partner who’s able to get pregnant, you should use birth control during the treatment and for 4 months after the final dose.
  • Tell your provider all of your medical history. Inform them about all the medications that you are currently taking, including over-the-counter and herbal medications.
  • Inform your provider if you are breastfeeding. You should not breastfeed during treatment and for at least 2 weeks after your final dose due to potential harm and side effects to your baby.

Get Copay Assistance Now

(866) 631-1684

Zepzelca Cost

Zepzelca is available as a powder for injection, with a strength of 4 mg per vial. The cost can vary significantly based on your location, treatment plan, insurance coverage, and the pharmacy you visit. However, on average, each vial of Zepzelca costs around $6,470 [4].

So, the overall treatment cost is very high. Before beginning your treatment, you should consult your provider and health insurance company about the cost. You should also explore various financial assistance programs.

자주 묻는 질문

Here are some frequently asked questions about Zepzelca:

1. Does Zepzelca cause hair loss?

Yes. Hair loss is a side effect of chemotherapy treatment with Zepzelca. In clinical trials, about 1% of patients receiving the medication experienced hair loss [5]. Consult your prescriber for possible remedies if you experience hair loss during treatment.

2. Can I use Zepzelca if I have liver problems?

If you have mild liver problems, then you can use Zepzelca. There is no need for dosage adjustments. However, there is still no data on patients with moderate to severe liver problems [2]. In such cases, you should consult your provider for further information.

3. What should I avoid while taking Zepzelca?

While taking this medication, you should take some precautions and avoid certain things to minimize side effects:

  • It can weaken your immune system. This makes you more likely to get infections. So, to decrease your chance of getting infections, you should avoid close contact with people who are sick and practice good hygiene.
  • You should avoid drinking alcohol. Alcohol can interfere with your liver. Since Zepzelca is processed through the liver, avoiding alcohol can help prevent liver-related complications.
  • You should avoid eating or drinking anything that contains grapefruit or Seville oranges. These products can raise the levels of Zepzelca in your body, which can raise your risk for side effects after chemotherapy.
이 정보는 의학적 조언이나 치료를 대체할 수 없습니다. 새로운 치료를 시작하기 전에 담당 의사 또는 의료 서비스 제공자와 건강 상태에 대해 상담하십시오. AmeriPharma® Specialty Care는 제공된 정보 또는 그 결과로 내려진 진단이나 치료에 대해 어떠한 책임도 지지 않으며, 콘텐츠의 신뢰성에 대해서도 책임을 지지 않습니다. AmeriPharma® Specialty Care는 여기에 나열된 모든 웹사이트/기관을 운영하는 것은 아니며, 해당 콘텐츠의 가용성이나 신뢰성에 대해서도 책임을 지지 않습니다. 이러한 목록은 AmeriPharma® Specialty Care의 보증, 후원 또는 추천을 암시하거나 구성하지 않습니다. 이 웹페이지에는 AmeriPharma® Specialty Care와 제휴하지 않은 제약 회사의 상표 또는 등록 상표인 브랜드 처방약에 대한 참조가 포함될 수 있습니다.
의학적으로 검토됨 로버트 하킴 박사, 약학박사

로버트 채드 하킴 박사(약학박사)는 캘리포니아주 노스리지에서 태어나고 자랐습니다. 그는 위스콘신-매디슨 대학교 약학대학에서 약학 학위를 받았습니다. 그의 업무에서 가장 보람 있는 부분은 환자 치료에 미치는 영향을 극대화하는 임상 프로그램을 발전시키는 데 앞장서는 것입니다. 그는 중환자 치료 전문 자격증(BCCCP)을 보유하고 있으며, 중환자 치료, 약물 정보, 일반 의학, 심장학 분야의 전문 분야를 다룹니다. 여가 시간에는 여행을 즐깁니다. 

문의하기

아래 HIPAA 규격 양식을 사용하여 처방전 재조제를 요청하세요. 복용 중인 약이나 복용 방법에 대한 문의 사항이 있으시면 문의하기 페이지를 방문하시거나 다음 번호로 전화해 주세요. (877) 778-0318.

HIPAA Compliant

제출하면 AmeriPharma에 동의하는 것입니다. 이용 약관, 개인정보 보호정책, 그리고 개인정보 보호 관행 고지

ko_KRKorean